Table 2.
Background characteristics and potential risk factors |
Contrast of Violence Categories | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||
Self-directed vs. none |
Other- directed vs. none |
Combined vs. none |
Other- directed vs. self- directed |
Combined vs. self- directed |
Combined vs. other- directed |
|||||||
|
|
|
|
|
|
|||||||
OR | 95%CI | OR | 95%CI | OR | 95%CI | OR | 95%CI | OR | 95%CI | OR | 95%CI | |
Sociodemographics | ||||||||||||
Gender | ||||||||||||
Male | 1.0 | 0.8–1.1 | 1.6** | 1.4–1.7 | 1.1 | 0.8–1.5 | 1.6** | 1.3–1.9 | 1.1 | 0.8–1.5 | 0.7* | 0.5–0.9 |
Female | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
Race/ethnicity | ||||||||||||
Non-Hispanic White | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
Non-Hispanic Black | 1.3* | 1.1–1.6 | 2.0** | 1.8–2.2 | 2.8** | 2.0–3.8 | 1.5** | 1.2–1.9 | 2.2** | 1.5–3.2 | 1.4* | 1.0–2.0 |
Non-Hispanic Native American/AK Native | 1.6 | 0.9–2.8 | 1.6** | 1.2–2.1 | 2.3* | 1.1–4.6 | 1.0 | 0.5–1.8 | 1.4 | 0.6–3.5 | 1.4 | 0.7–2.9 |
Non-Hispanic Native HI/other Pacific Islander | 0.7 | 0.2–2.9 | 2.0 | 1.0–3.9 | 1.7 | 0.3–8.2 | 2.9 | 0.6–14.2 | 2.5 | 0.3–23.2 | 0.9 | 0.2–4.7 |
Non-Hispanic Asian | 1.8* | 1.1–2.9 | 1.0 | 0.7–1.4 | 1.1 | 0.4–2.7 | 0.6* | 0.3–1.0 | 0.6 | 0.2–1.6 | 1.1 | 0.4–3.0 |
Non-Hispanic more than one race | 1.3 | 0.9–1.9 | 1.8** | 1.3–2.5 | 2.8** | 1.4–5.5 | 1.4 | 0.9–2.1 | 2.1* | 1.0–4.6 | 1.6 | 0.8–3.1 |
Hispanic | 1.2 | 1.0–1.4 | 1.3** | 1.1–1.5 | 1.2 | 0.8–1.8 | 1.1 | 0.9–1.4 | 1.0 | 0.7–1.6 | 1.0 | 0.6–1.4 |
Age | ||||||||||||
8–20 | 2.4** | 1.9–3.1 | 3.7** | 3.2–4.3 | 7.1** | 4.3–11.7 | 1.6** | 1.1–2.1 | 2.9** | 1.7–5.2 | 1.9* | 1.1–3.2 |
21–25 | 1.4** | 1.1–1.7 | 2.5** | 2.2–2.9 | 4.0** | 2.4–6.5 | 1.8** | 1.4–2.4 | 2.9** | 1.6–5.0 | 1.6 | 1.0–2.7 |
26–34 | 0.9 | 0.7–1.2 | 1.7** | 1.4–1.9 | 1.7 | 0.9–3.1 | 1.8** | 1.3–2.4 | 1.8 | 0.9–3.4 | 1.0 | 0.6–1.8 |
35–49 | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
50+ | 0.9 | 0.7–1.2 | 0.8* | 0.7–1.0 | 0.6 | 0.2–1.4 | 0.9 | 0.7–1.2 | 0.6 | 0.3–1.6 | 0.7 | 0.3–1.7 |
Education | ||||||||||||
Less than high school | 1.2* | 1.0–1.5 | 1.4** | 1.2–1.6 | 1.5* | 1.1–2.2 | 1.1 | 0.9–1.4 | 1.3 | 0.9–1.8 | 1.1 | 0.8–1.6 |
High school | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
Some college | 0.9 | 0.7–1.1 | 0.8** | 0.7–0.9 | 0.8 | 0.6–1.3 | 0.9 | 0.7–1.1 | 0.9 | 0.6–1.5 | 1.1 | 0.7–1.6 |
College graduate | 0.7** | 0.6–0.9 | 0.4** | 0.4–0.5 | 0.3** | 0.1–0.6 | 0.6** | 0.4–0.8 | 0.4* | 0.2–0.9 | 0.7 | 0.3–1.5 |
Marital status | ||||||||||||
Married | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
Widowed | 1.1 | 0.7–1.7 | 1.9** | 1.4–2.8 | 3.4* | 1.2–9.9 | 1.8 | 1.0–3.3 | 3.2* | 1.0–9.8 | 1.8 | 0.6–5.0 |
Divorced or separated | 1.5** | 1.2–2.0 | 1.4** | 1.2–1.8 | 2.5** | 1.5–4.2 | 0.9 | 0.7–1.3 | 1.6 | 0.9–2.9 | 1.7 | 1.0–3.0 |
Never married | 1.2 | 0.9–1.5 | 1.5** | 1.3–1.8 | 1.2 | 0.7–1.8 | 1.3 | 1.0–1.7 | 1.0 | 0.6–1.6 | 0.8 | 0.5–1.2 |
Family income | ||||||||||||
Less than $10,000 | 1.5** | 1.2–1.8 | 1.1 | 0.9–1.2 | 1.2 | 0.7–1.8 | 0.7* | 0.6–0.9 | 0.8 | 0.5–1.3 | 1.1 | 0.7–1.7 |
$10,000–$29,999 | 1.2* | 1.0–1.5 | 1.1* | 1.0–1.3 | 1.1 | 0.8–1.6 | 0.9 | 0.7–1.2 | 0.9 | 0.6–1.3 | 1.0 | 0.7–1.4 |
$30,000–$74,999 | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
$75,000+ | 0.8 | 0.6–1.0 | 1.0 | 0.8–1.1 | 0.6 | 0.4–1.0 | 1.2 | 0.9–1.6 | 0.8 | 0.4–1.4 | 0.7 | 0.4–1.1 |
Substance use disordersa | ||||||||||||
Alcohol use disorders (past year) | ||||||||||||
0–1 criteria | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
2–3 criteria | 1.7** | 1.3–2.2 | 2.1** | 1.9–2.4 | 1.8* | 1.1–3.0 | 1.2 | 0.9–1.6 | 1.1 | 0.6–1.9 | 0.9 | 0.5–1.4 |
4+ criteria | 2.0** | 1.6–2.5 | 2.6** | 2.3–2.9 | 3.1** | 2.1–4.6 | 1.3* | 1.0–1.6 | 1.6* | 1.0–2.4 | 1.2 | 0.8–1.8 |
Nicotine dependence (past month) | ||||||||||||
No | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
Yes | 1.3** | 1.1–1.6 | 1.5** | 1.3–1.7 | 1.7** | 1.3–2.4 | 1.1 | 0.9–1.4 | 1.3 | 0.9–1.9 | 1.2 | 0.8–1.6 |
Marijuana use disorders (past year) | ||||||||||||
0–1 criteria | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
2–3 criteria | 1.1 | 0.9–1.4 | 1.6** | 1.4–1.8 | 2.0** | 1.3–3.1 | 1.4** | 1.1–1.8 | 1.7* | 1.1–2.9 | 1.2 | 0.8–1.9 |
4+ criteria | 1.0 | 0.7–1.5 | 1.6** | 1.4–1.9 | 1.3 | 0.8–2.1 | 1.6* | 1.0–2.5 | 1.3 | 0.7–2.4 | 0.8 | 0.5–1.3 |
Cocaine use disorders (past year) | ||||||||||||
0–1 criteria | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
2–3 criteria | 0.7 | 0.2–2.0 | 1.1 | 0.8–1.7 | 2.5* | 1.1–5.7 | 1.7 | 0.5–5.6 | 3.7* | 1.2–11.9 | 2.2 | 1.0–5.1 |
4+ criteria | 1.4 | 0.9–2.1 | 1.6* | 1.0–2.4 | 2.8** | 1.5–5.1 | 1.1 | 0.7–1.9 | 2.0* | 1.1–3.9 | 1.8 | 1.0–3.3 |
Hallucinogen use disorders (past year) | ||||||||||||
0–1 criteria | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
2–3 criteria | 1.7 | 0.8–3.8 | 1.4 | 0.9–2.3 | 1.4 | 0.5–4.1 | 0.8 | 0.4–1.8 | 0.8 | 0.3–2.5 | 1.0 | 0.4–2.6 |
4+ criteria | 2.0 | 0.8–4.8 | 1.5 | 0.7–3.0 | 1.9 | 0.7–5.1 | 0.7 | 0.3–1.8 | 1.0 | 0.3–2.7 | 1.3 | 0.5–3.1 |
Heroin use disorders (past year) | ||||||||||||
0–1 criteria | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
2+ criteria | 0.8 | 0.4–1.4 | 1.3 | 0.8–1.9 | 0.5 | 0.2–1.0 | 1.6 | 0.8–3.2 | 0.6 | 0.2–1.4 | 0.4* | 0.1–0.9 |
Inhalant use disorders (past year) | ||||||||||||
0–1 criteria | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
2+ criteria | 3.5* | 1.3–9.2 | 0.9 | 0.5–1.8 | 1.8 | 0.5–6.3 | 0.3** | 0.1–0.7 | 0.5 | 0.1–1.9 | 2.0 | 0.6–7.1 |
Pain reliever use disorders (past year) | ||||||||||||
0–1 criteria | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
2–3 criteria | 1.4 | 1.0–2.1 | 1.8** | 1.3–2.5 | 1.6 | 0.9–2.7 | 1.3 | 0.8–2.1 | 1.1 | 0.6–2.0 | 0.9 | 0.5–1.6 |
4+ criteria | 1.6* | 1.1–2.4 | 1.5** | 1.2–1.9 | 3.1** | 1.8–5.2 | 0.9 | 0.6–1.5 | 1.9* | 1.0–3.6 | 2.0* | 1.1–3.6 |
Sedative use disorders (past year) | ||||||||||||
0–1 criteria | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
2+ criteria | 1.7 | 0.9–3.4 | 1.5 | 0.8–2.5 | 1.1 | 0.3–4.0 | 0.9 | 0.4–1.7 | 0.6 | 0.2–2.3 | 0.7 | 0.2–2.5 |
Stimulant use disorders (past year) | ||||||||||||
0–1 criteria | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
2–3 criteria | 2.0* | 1.1–3.5 | 0.9 | 0.6–1.4 | 0.9 | 0.4–2.3 | 0.5* | 0.2–0.9 | 0.5 | 0.2–1.2 | 1.0 | 0.4–2.6 |
4+ criteria | 0.9 | 0.5–1.9 | 1.4 | 0.8–2.4 | 2.6* | 1.3–5.5 | 1.5 | 0.7–3.4 | 2.8* | 1.1–7.1 | 1.9 | 0.9–3.8 |
Tranquilizer use disorders (past year) | ||||||||||||
0–1 criteria | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
2–3 criteria | 1.5 | 0.8–2.7 | 1.6* | 1.1–2.5 | 1.5 | 0.5–4.2 | 1.1 | 0.5–2.2 | 1.0 | 0.4–2.7 | 0.9 | 0.3–2.7 |
4+ criteria | 1.3 | 0.8–2.3 | 0.8 | 0.4–1.5 | 0.6 | 0.2–1.6 | 0.6 | 0.3–1.1 | 0.4 | 0.2–1.1 | 0.7 | 0.3–2.0 |
Serious psychological distress (past year) | ||||||||||||
No | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
Yes | 7.8** | 6.3–9.6 | 2.6** | 2.3–3.0 | 20.0** | 12.1–33.1 | 0.3** | 0.3–0.4 | 2.6** | 1.5–4.5 | 7.6** | 4.5–12.7 |
Major depressive episode (past year) | ||||||||||||
No | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
Yes | 3.0** | 2.5–3.5 | 1.4** | 1.2–1.6 | 3.1** | 2.1–4.7 | 0.5** | 0.4–0.6 | 1.1 | 0.7–1.6 | 2.3** | 1.4–3.6 |
Criminal justice involvement (past year) | ||||||||||||
No | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
Yes | 1.6** | 1.3–2.1 | 1.7** | 1.4–1.9 | 1.5 | 1.0–2.2 | 1.0 | 0.8–1.4 | 0.9 | 0.6–1.5 | 0.9 | 0.6–1.3 |
Assault arrest (past year) | ||||||||||||
No | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref | 1.0 | Ref |
Yes | 2.9** | 1.8–4.5 | 6.9** | 5.7–8.4 | 9.2** | 5.7–15.1 | 2.4** | 1.5–3.8 | 3.2** | 1.7–6.2 | 1.3 | 0.8–2.2 |
OR, odds ratio; CI, confidence interval; Ref, reference category.
Alcohol use disorder, marijuana use disorder, and other drug use disorders in the past year were based on the original DSM-IV criteria excluding the criterion of legal problems. However, nicotine dependence in the past month was assessed based on the dependence criteria according to the Nicotine Dependence Syndrome Scale (NDSS) and the Fagerström Test of Nicotine Dependence (FTND).
p < 0.05;
p < 0.01
Note: All the predictors are significant (p < 0.01) based on adjusted Wald test, except the number of criteria for cocaine use disorders (p = 0.0200), hallucinogen use disorders (p = 0.5362), heroin use disorders (p = 0.1788), Inhalant use disorders (p = 0.0399), sedative use disorders (p = 0.3654), stimulant use disorders (p = 0.0237), and tranquilizer use disorders (p = 0.0521).